Michael Narachi

Michael A. Narachi is an Independent Director at Ultragenyx Pharmaceutical, Inc. since 2015.
Formerly, Mr. Narachi was President, Chief Executive Officer & Director at CODA Biotherapeutics, Inc. from 2018 to 2022; President, Chief Executive Officer & Director at Orexigen Therapeutics, Inc. from 2016 to 2018; Chairman, President & Chief Executive Officer at Ren Pharmaceuticals, Inc. from 2006 to 2009; Chairman at Celladon Corp.
from 2013 to 2016; Executive Chairman at Naryx Pharma, Inc. from 2002 to 2008; Director at Pharmaceutical Research & Manufacturers of America from 2013 to 2017; Director at AMAG Pharmaceuticals, Inc. in 2014; Vice President at Amgen, Inc. from 1984 to 2003; and held director and vice president roles at Thousand Oaks Corp., Biotechnology Innovation Organization, and Amgen KK.
Education includes undergraduate and graduate degrees from the University of California, Davis, and an MBA from UCLA Anderson School of Management.